Skip to main content
. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088

Fig 3.

Fig 3

Adjusted odds ratios for confirmed cases of covid-19 by interval after vaccination with Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S from 4 January 2021